生物医药

1. 代谢疾病的分子机理
2. 抗肥胖药物开发及应用

1. Sun W#, Nie T#, Li K#, Wu W, Long Q, Feng T, Mao L, Gao Y, Liu Q, Gao X et al: Hepatic CPT1A Facilitates Liver-Adipose Cross-Talk via Induction of FGF21 in Mice. Diabetes 2022; 71 (1): 31–42.
2. Sun W#, Zhao X#, Wang Z, Chu Y, Mao L, Lin S, Gao X, Song Y, Hui X, Jia S et al: Tbx15 is required for adipocyte browning induced by adrenergic signaling pathway. Mol Metab 2019, 28:48-57.
3. Tang R#, Sun W#, Zhang JC, Mao L, Quanquin N, Wu D, Sun Y: Expression of Human Uncoupling Protein-1 in Escherichia coli Decreases its Survival Under Extremely Acidic Conditions. Curr Microbiol 2022, 79(3):77.
4. Sun W#, Lai Y, Li H, Nie T, Kuang Y, Tang X, Li K, Dunbar PR, Xu A, Li P et al: High level expression and purification of active recombinant human interleukin-15 in Pichia pastoris. J Immunol Methods 2016, 428:50-57.

国家自然科学基金青年项目（82200646），锌指蛋白PRDM16在非酒精性脂肪肝发生中的作用机制研究，2023/01-2025/12，主持。